Development, validation and evaluation of learning activities to support the reporting of adverse drug reactions during the COVID-19 pandemic

Authors

  • Elisa Curtolo University of Malta, Msida, Malta
  • Janis Vella Szijj University of Malta, Msida, Malta
  • Liberato Camilleri University of Malta, Msida, Malta
  • Anthony Serracino-Inglott University of Malta, Msida, Malta
  • Lilian M. Azzopardi University of Malta, Msida, Malta

DOI:

https://doi.org/10.46542/pe.2022.221.515522

Keywords:

Adverse drug reaction reporting, COVID-19 vaccine, Education, Healthcare professional, Pharmacovigillance, Underreporting

Abstract

Background: The fast tracking of the production of COVID-19 vaccines gave rise to aspects of general concern regarding their safety. The vigilance aspect of adverse drug reaction (ADR) reporting is a means to build up the science behind the safety aspects. The aim was to develop, validate and apply learning activities for healthcare professionals (HCPs) to educate and support them on ADR reporting.   

Methods: Two educational webinars were developed, validated, applied and evaluated by pharmacists, medical doctors, dentists and nurses.    

Results: Evaluation forms about the webinars were completed by 103 out of 132 HCPs (first webinar), and 73 out of 90 HCPs (second webinar).    

Conclusion: HCPs agreed that the educational webinars made them more aware of the importance of ADR reporting and the webinars helped them overcome barriers to ADR reporting.

Author Biographies

Elisa Curtolo, University of Malta, Msida, Malta

Department of Pharmacy, Faculty of Medicine and Surgery

Janis Vella Szijj, University of Malta, Msida, Malta

Department of Pharmacy, Faculty of Medicine and Surgery

Liberato Camilleri, University of Malta, Msida, Malta

Department of Statistics and Operations Research, Faculty of Science

Anthony Serracino-Inglott, University of Malta, Msida, Malta

Department of Pharmacy, Faculty of Medicine and Surgery

Lilian M. Azzopardi, University of Malta, Msida, Malta

Department of Pharmacy, Faculty of Medicine and Surgery

References

Al Rabayah, A. A., Hanoun, E. M., & Al Rumman, R. H. (2019). Assessing knowledge, attitude, and practices of healthcare providers toward pharmacovigilance and adverse drug reaction reporting at a comprehensive cancer center in Jordan. Perspectives in clinical research, 10(3), 115–120. https://doi.org/10.4103/picr.PICR_4_18

AlShammari, T. M., & Almoslem, M. J. (2018). Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: A multi-centre cross sectional study. Saudi pharmaceutical journal, 26(7), 925–931. https://doi.org/10.1016/j.jsps.2018.04.012

Ali, M. D., Hassan, Y. A., Ahmad, A., Alaqel, O., Al-Harbi, H., & Al-Suhaimi, N. M. (2018). Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia. Current drug safety, 13(1), 21–25. https://doi.org/10.2174/1574886313666171218123802

Biagi, C., Montanaro, N., Buccellato, E., Roberto, G., Vaccheri, A., & Motola, D. (2013). Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region). European journal of clinical pharmacology, 69(2), 237–244. https://doi.org/10.1007/s00228-012-1321-7

Borg, J. J., Aislaitner, G., Pirozynski, M., & Mifsud, S. (2011). Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance. Drug safety, 34(3), 187–197. https://doi.org/10.2165/11586620-000000000-00000

Borg, J. J., Serracino-Inglott, A., & Al-Haddad, D. (2018). A review of the national Adverse Drug Reaction (ADR) & Medication Error reporting system of Malta. Malta Medical School Gazette, 2(1),4-10

Bouvy, J. C., De Bruin, M. L., & Koopmanschap, M. A. (2015). Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug safety, 38(5), 437–453. https://doi.org/10.1007/s40264-015-0281-0

Cereza, G., Agustí, A., Pedrós, C., Vallano, A., Aguilera, C., Danés, I., Vidal, X., & Arnau, J. M. (2010). Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital. European journal of clinical pharmacology, 66(9), 937–945. https://doi.org/10.1007/s00228-010-0856-8

Cheema, E., Almualem, A. A., Basudan, A. T., Salamatullah, A. K., Radhwi, S. O., & Alsehli, A. S. (2019). Assessing the impact of structured education on the knowledge of hospital pharmacists about adverse drug reactions and reporting methods in Saudi Arabia: an open-label randomised controlled trial. Drugs & therapy perspectives: for rational drug selection and use, 35(6), 296–300. https://doi.org/10.1007/s40267-019-00621-z

European Medicines Agency. (2021a). Pharmacovigilance: Overview. Retrieved 11 May 2021, from https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview

European Medicines Agency. (2021b). Eudravigilance - European database of suspected adverse drug reaction reports. Retrieved 11 May 2021, from https://www.adrreports.eu/index.html

Figueiras, A., Herdeiro, M. T., Polónia, J., & Gestal-Otero, J. J. (2006). An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA, 296(9), 1086–1093. https://doi.org/10.1001/jama.296.9.1086

Formica, D., Sultana, J., Cutroneo, P. M., Lucchesi, S., Angelica, R., Crisafulli, S., Ingrasciotta, Y., Salvo, F., Spina, E., & Trifirò, G. (2018). The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert opinion on drug safety, 17(7), 681–695. https://doi.org/10.1080/14740338.2018.1491547

Ganesan, S., Sandhiya, S., Reddy, K. C., Subrahmanyam, D. K., & Adithan, C. (2017). The Impact of the Educational Intervention on Knowledge, Attitude, and Practice of Pharmacovigilance toward Adverse Drug Reactions Reporting among Healthcare Professionals in a Tertiary Care Hospital in South India. Journal of natural science, biology, and medicine, 8(2), 203–209. https://doi.org/10.4103/0976-9668.210014

Gony, M., Badie, K., Sommet, A., Jacquot, J., Baudrin, D., Gauthier, P., Montastruc, J. L., & Bagheri, H. (2010). Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study. Drug safety, 33(5), 409–416. https://doi.org/10.2165/11319170-000000000-00000

Hadi, M. A., Neoh, C. F., Zin, R. M., Elrggal, M. E., & Cheema, E. (2017). Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting. Integrated pharmacy research & practice, 6, 91–98. https://doi.org/10.2147/IPRP.S105881

Hailu, A. D., & Mohammed, S. A. (2020). Adverse Drug Reaction Reporting in Ethiopia: Systematic Review. BioMed research international, 2020, 8569314. https://doi.org/10.1155/2020/8569314

Herdeiro, M. T., Polónia, J., Gestal-Otero, J. J., & Figueiras, A. (2008). Improving the reporting of adverse drug reactions: a cluster-randomized trial among pharmacists in Portugal. Drug safety, 31(4), 335–344. https://doi.org/10.2165/00002018-200831040-00007

Herdeiro, M. T., Ribeiro-Vaz, I., Ferreira, M., Polónia, J., Falcão, A., & Figueiras, A. (2012). Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal. Drug safety, 35(8), 655–665. https://doi.org/10.1007/BF03261962

Jha, N., Rathore, D. S., Shankar, P. R., Gyawali, S., Alshakka, M., & Bhandary, S. (2014). An educational intervention's effect on healthcare professionals' attitudes towards pharmacovigilance. The Australasian medical journal, 7(12), 478–489. https://doi.org/10.4066/AMJ.2014.2235

Johansson, M. L., Brunlöf, G., Edward, C., & Wallerstedt, S. M. (2009). Effects of emails containing ADR information and a current case report on ADR reporting rate and quality of reports. European journal of clinical pharmacology, 65(5), 511–514. https://doi.org/10.1007/s00228-008-0603-6

Johansson, M. L., Hägg, S., & Wallerstedt, S. M. (2011). Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study. BMC clinical pharmacology, 11, 14. https://doi.org/10.1186/1472-6904-11-14

Khalil, H., & Huang, C. (2020). Adverse drug reactions in primary care: a scoping review. BioMed Central Health Services Research, 20(1), 5. https://doi.org/10.1186/s12913-019-4651-7

Klika, C., Kaeding, M., & Schmälter, J. (2017). The EU Pharmacovigilance System and Adverse Drug Reaction Reporting in Practice: A Critical Assessment. European Journal of Risk Regulation, 8(4), 772-778. https://doi.org/10.1017/err.2017.67

Lemay, J., Alsaleh, F. M., Al-Buresli, L., Al-Mutairi, M., Abahussain, E. A., & Bayoud, T. (2018). Reporting of Adverse Drug Reactions in Primary Care Settings in Kuwait: A Comparative Study of Physicians and Pharmacists. Medical principles and practice: international journal of the Kuwait University, Health Science Centre, 27(1), 30–38. https://doi.org/10.1159/000487236

Lopez-Gonzalez, E., Herdeiro, M. T., & Figueiras, A. (2009). Determinants of under-reporting of adverse drug reactions: a systematic review. Drug safety, 32(1), 19–31. https://doi.org/10.2165/00002018-200932010-00002

Lopez-Gonzalez, E., Herdeiro, M. T., Piñeiro-Lamas, M., Figueiras, A., & GREPHEPI group (2015). Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial. Drug safety, 38(2), 189–196. https://doi.org/10.1007/s40264-014-0256-6

Nisa, Z. U., Zafar, A., & Sher, F. (2018). Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan. Saudi pharmaceutical journal, 26(4), 453–461. https://doi.org/10.1016/j.jsps.2018.02.014

Opadeyi, A. O., Fourrier-Réglat, A., & Isah, A. O. (2019). Educational intervention to improve the knowledge, attitude and practice of healthcare professionals regarding pharmacovigilance in South-South Nigeria. Therapeutic advances in drug safety, 10, 2042098618816279. https://doi.org/10.1177/2042098618816279

Palleria, C., Leporini, C., Chimirri, S., Marrazzo, G., Sacchetta, S., Bruno, L., Lista, R. M., Staltari, O., Scuteri, A., Scicchitano, F., & Russo, E. (2013). Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two “challenging” case reports. Journal of pharmacology & pharmacotherapeutics, 4(Suppl1), S66-S72. https://doi.org/10.4103/0976-500X.120955

Pedrós, C., Vallano, A., Cereza, G., Mendoza-Aran, G., Agustí, A., Aguilera, C., Danés, I., Vidal, X., & Arnau, J. M. (2009). An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug safety, 32(1), 77–83. https://doi.org/10.2165/00002018-200932010-00007

Petousis-Harris, H. (2020). Assessing the Safety of COVID-19 Vaccines: A Primer. Drug Safety, 43(12), 1205-1210. https://doi.org/10.1007/s40264-020-01002-6

Primo, L. P., & Capucho, H. C. (2011). Intervenções educativas para estímulo a notificações voluntárias em um hospital de ensino da rede sentinela. Revista Brasileira de farmácia hospitalar e serviços de saúde, 2(2)

Ribeiro-Vaz, I., Herdeiro, M. T., Polónia, J., & Figueiras, A. (2011). Strategies to increase the sensitivity of pharmacovigilance in Portugal. Revista de saude publica, 45(1), 129–135. https://doi.org/10.1590/s0034-89102010005000050

Salehi, T., Seyedfatemi, N., Mirzaee, M. S., Maleki, M., & Mardani, A. (2021). Nurses' Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review. BioMed research international, 2021, 6630404. https://doi.org/10.1155/2021/6630404

Santoro, A., Genov, G., Spooner, A., Raine, J., & Arlett, P. (2017). Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works. Drug safety, 40(10), 855–869. https://doi.org/10.1007/s40264-017-0572-8

Schutte, T., van Eekeren, R., Richir, M., van Staveren, J., van Puijenbroek, E., Tichelaar, J., & van Agtmael, M. (2018). The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study. Naunyn-Schmiedeberg's archives of pharmacology, 391(1), 17-26. https://doi.org/10.1007/s00210-017-1430-z

Shakir, S., Lane, S., & Davies, M. (2021). How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine. Drug safety, 44(1), 1–5. https://doi.org/10.1007/s40264-020-01018-y

Shrestha, S., Sharma, S., Bhasima, R., Kunwor, P., Adhikari, B., & Sapkota, B. (2020). Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital. BMC medical education, 20(1), 179. https://doi.org/10.1186/s12909-020-02084-7

Varallo, F. R., Planeta, C. S., & Mastroianni, P. C. (2017). Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff. Clinics (Sao Paulo, Brazil), 72(1), 51–57. https://doi.org/10.6061/clinics/2017(01)09

Venkatasubbaiah, M., Reddy, P. D. & Satyanarayana, S. V. (2021). Knowledge, attitude, and practices (KAP) of the Pharm.D interns towards adverse drug reaction (ADR) reporting and pharmacovigilance. Pharmacy Education, 21(1), 186-193. https://doi.org/10.46542/pe.2021.211.186193

Downloads

Published

2022-06-02

How to Cite

Curtolo, E., Szijj, J. V., Camilleri, L., Serracino-Inglott, A., & Azzopardi, L. M. (2022). Development, validation and evaluation of learning activities to support the reporting of adverse drug reactions during the COVID-19 pandemic. Pharmacy Education, 22(1), p. 515–522. https://doi.org/10.46542/pe.2022.221.515522

Issue

Section

Research Article